Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Screening and Assessment for Alzheimer’s Disease in the Days of Biological Biomarkers

Journal of Alzheimer s Disease(2023)10.3233/jad-230215Source: DataRank Database

Screening and Assessment for Alzheimer’s Disease in the Days of Biological Biomarkers is a research paper published in Journal of Alzheimer s Disease (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Hugh C. Hendrie ORCID

Live enrichment

PubMed:37066918 PMC:PMC10846840 OpenAlex:https://openalex.org/W4364361045

NIA NIH HHS

Grant: P30 AG072976

NIA NIH HHS

Grant: P30 AG010133

National Institutes of Health

Grant: 5P30AG072976-02

Indiana Alzheimer's Disease Research Center

FWCI

0.00

Citation Percentile

0.1%

green

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/4dd98107-6707-494b-87d8-75a3dad91943/download

publisherhttps://content.iospress.com/download?id=10.3233/JAD-230215

repositoryhttps://hdl.handle.net/1805/41381

journalhttps://doi.org/10.3233/jad-230215

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsHumansAlzheimer DiseaseEthnicityMinority GroupsCognitive DysfunctionBiomarkersDisease Progression

MeSH Terms

Alzheimer DiseaseEthnicityHumansMinority GroupsBiomarkersDisease ProgressionCognitive Dysfunction

Keywords

DementiaDiseaseCognitive declineMedicineAlzheimer's diseaseGerontologyPsychologyPsychiatryInternal medicineAlzheimer’s diseasebiological markersStandardized Assessment ToolsEthnic Minority RepresentationAlzheimer DiseaseEthnicityDisease ProgressionHumansCognitive DysfunctionMinority GroupsBiomarkers

Sustainable Development Goals

SDG 0: Reduced inequalities